Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3,5-ditpa
2. Ditpa Cpd
1. 1158-10-7
2. Ditpa
3. 3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic Acid
4. 3,5-ditpa
5. Benzenepropanoic Acid, 4-(4-hydroxyphenoxy)-3,5-diiodo-
6. 3 5-diiodothyropropionic Acid
7. 1hto2x0sj9
8. Chembl2348292
9. 3,5-diiodo-4-(4-hydroxyphenoxy)hydrocinnamic Acid
10. Dipta
11. 3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoic Acid
12. Dipro
13. Unii-1hto2x0sj9
14. Diiodothyropropionic-acid
15. 3,5-diiodothyropropanoic Acid
16. Schembl1501771
17. Benzenepropanoic Acid,4-(4-hydroxyphenoxy)-3,5-diiodo-
18. Dtxsid8040939
19. Chebi:134267
20. Zinc3972069
21. Bdbm50431457
22. Akos005174585
23. Db12629
24. Hy-126236
25. Bb 0266169
26. Cs-0100519
27. J-003326
28. Q27252433
29. 3-(4-(4-hydroxyphenoxy)-3,5-diiodophenyl)propanoicacid
30. 3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propionic Acid
Molecular Weight | 510.06 g/mol |
---|---|
Molecular Formula | C15H12I2O4 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 509.88250 g/mol |
Monoisotopic Mass | 509.88250 g/mol |
Topological Polar Surface Area | 66.8 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 333 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Hormones
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. (See all compounds classified as Hormones.)
ABOUT THIS PAGE
A 3-5-Diiodothyropropionic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3-5-Diiodothyropropionic Acid, including repackagers and relabelers. The FDA regulates 3-5-Diiodothyropropionic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3-5-Diiodothyropropionic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3-5-Diiodothyropropionic Acid supplier is an individual or a company that provides 3-5-Diiodothyropropionic Acid active pharmaceutical ingredient (API) or 3-5-Diiodothyropropionic Acid finished formulations upon request. The 3-5-Diiodothyropropionic Acid suppliers may include 3-5-Diiodothyropropionic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 3-5-Diiodothyropropionic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 3-5-Diiodothyropropionic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 3-5-Diiodothyropropionic Acid active pharmaceutical ingredient (API) in detail. Different forms of 3-5-Diiodothyropropionic Acid DMFs exist exist since differing nations have different regulations, such as 3-5-Diiodothyropropionic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3-5-Diiodothyropropionic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 3-5-Diiodothyropropionic Acid USDMF includes data on 3-5-Diiodothyropropionic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3-5-Diiodothyropropionic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3-5-Diiodothyropropionic Acid suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 3-5-Diiodothyropropionic Acid Drug Master File in Japan (3-5-Diiodothyropropionic Acid JDMF) empowers 3-5-Diiodothyropropionic Acid API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 3-5-Diiodothyropropionic Acid JDMF during the approval evaluation for pharmaceutical products. At the time of 3-5-Diiodothyropropionic Acid JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 3-5-Diiodothyropropionic Acid suppliers with JDMF on PharmaCompass.
3-5-Diiodothyropropionic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3-5-Diiodothyropropionic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3-5-Diiodothyropropionic Acid GMP manufacturer or 3-5-Diiodothyropropionic Acid GMP API supplier for your needs.
A 3-5-Diiodothyropropionic Acid CoA (Certificate of Analysis) is a formal document that attests to 3-5-Diiodothyropropionic Acid's compliance with 3-5-Diiodothyropropionic Acid specifications and serves as a tool for batch-level quality control.
3-5-Diiodothyropropionic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 3-5-Diiodothyropropionic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3-5-Diiodothyropropionic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (3-5-Diiodothyropropionic Acid EP), 3-5-Diiodothyropropionic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3-5-Diiodothyropropionic Acid USP).
LOOKING FOR A SUPPLIER?